Filing metadata

Accession number
0001492422-25-000009
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Oct 17, 2025
Reporting period
Oct 16, 2025
Description
Insider transaction

Explore SEC Filings Hub